1. Home
  2. GLDG vs STRO Comparison

GLDG vs STRO Comparison

Compare GLDG & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoldMining Inc.

GLDG

GoldMining Inc.

N/A

Current Price

$0.78

Market Cap

167.6M

ML Signal

N/A

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

N/A

Current Price

$9.57

Market Cap

159.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GLDG
STRO
Founded
2009
2003
Country
Canada
United States
Employees
N/A
128
Industry
Precious Metals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.6M
159.5M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
GLDG
STRO
Price
$0.78
$9.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
14
Target Price
$3.14
★ $47.23
AVG Volume (30 Days)
★ 552.8K
323.7K
Earning Date
10-14-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $38,419,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.71
$0.72
52 Week High
$2.27
$43.85

Technical Indicators

Market Signals
Indicator
GLDG
STRO
Relative Strength Index (RSI) 43.19 35.55
Support Level N/A $8.11
Resistance Level $0.90 $11.80
Average True Range (ATR) 0.04 0.82
MACD 0.01 0.25
Stochastic Oscillator 54.07 41.46

Price Performance

Historical Comparison
GLDG
STRO

About GLDG GoldMining Inc.

GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. Its principal projects are the La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia; the Sao Jorge Gold Project, located in Brazil; and its interest in the Whistler Gold-Copper Project, located in Alaska, United States. Additionally, the company has several other projects in its portfolio, such as the Yellowknife Gold Project, Cachoeira Gold Project, Surubim Gold Project, Yarumalito Gold Project, Rea Uranium Project, etc. The firm has two operating segments, with U.S. GoldMining as one distinct operating segment and all other subsidiaries, or Others, being the second operating segment.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: